Covidien (COV) - FREE Research Report

Green Eric C who is Vice President at Covidien sold 3,440 shares at $60.84 on Oct. 1, 2013. Following this transaction, the Vice President owned 20,093 shares meaning that the stake was reduced by 14.62% with the 3,440 share transaction.

The shares most recently traded at $60.66, down $0.18, or 0.3% since the insider transaction. Historical insider transactions for Covidien go as follows:

  • 4-Week # shares sold: 16,200
  • 12-Week # shares sold: 16,591
  • 24-Week # shares sold: 35,771

The average volume for Covidien has been 2.3 million shares per day over the past 30 days. Covidien has a market cap of $28.5 billion and is part of the health care sector and health services industry. Shares are up 7.27% year to date as of the close of trading on Tuesday.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. The stock currently has a dividend yield of 2.07%. The company has a P/E ratio of 15.5. Currently there are 13 analysts that rate Covidien a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on COV - FREE

TheStreet Quant Ratings rates Covidien as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures, notable return on equity and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Covidien Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Walgreens Is Primed to Rally, With or Without Rite Aid

S&P 500 and Dow Score Records With Wall Street Upbeat Ahead of Fed

S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed

Walgreens to Tweak Number of Rite Aid Stores It Buys to Win Regulatory Approval

Will the FTC Let Walgreens Go on a $5.2 Billion Rite Aid Shopping Spree?